Pesg report: inspira technologies' ai-powered respiratory system could revolutionize care for 20 million annual icu patients in combined $25+ billion market

New york--(business wire)---- $iinn #biotech--pesg research releases an update following inspira technologies' (nasdaq: iinn)* recent strategic developments and clinical achievements: inspira has emerged as a potential disruptive force in respiratory care with its integrated technology approach. the company's recent clinical studies demonstrating 96% accuracy for its ai-powered hyla blood sensor represent a significant technological validation as it targets multiple high-value healthcare segments. inspira's integ.
IINN Ratings Summary
IINN Quant Ranking